Literature DB >> 35932021

The pancreas-to-muscle signal intensity ratio on T1-weighted MRI as a predictive biomarker for postoperative pancreatic fistula after distal pancreatectomy: a single-center retrospective study.

Masahiro Fukada1, Katsutoshi Murase2, Toshiya Higashi2, Seito Fujibayashi2, Masashi Kuno2, Itaru Yasufuku2, Yuta Sato2, Shigeru Kiyama2, Yoshihiro Tanaka2, Naoki Okumura2, Nobuhisa Matsuhashi2, Takao Takahashi2.   

Abstract

BACKGROUND: Postoperative pancreatic fistula (POPF) is one of the serious complications of pancreatic surgery. When POPF occurs and becomes severe, it causes secondary complications and a longer treatment period. We previously reported a correlation between pancreatic fibrosis and magnetic resonance imaging (MRI) findings, and MRI may have the potential to predict POPF. This study aimed to assess the predictive ability of the pancreas-to-muscle signal intensity ratio on T1-weighted MRI (SIR on T1-w MRI) for POPF after distal pancreatectomy (DP).
METHODS: This single-institution retrospective study comprised 117 patients who underwent DP. It was conducted between 2010 and 2021 at the Gifu University Hospital. We statistically analyzed pre-, intra-, and postoperative factors to assess the correlation with POPF.
RESULTS: According to the definition and grading of the International Study Group of Pancreatic Fistula (ISGPF), 29 (24.8%) of the 117 patients had POPF grades B and C. In the univariate analysis, POPF was significantly associated with the pancreas-to-muscle SIR on T1-w MRI, the drainage fluid amylase concentration (D-Amy) levels on postoperative day (POD) 1 and 3, white blood cell count on POD 1 and 3, C-reactive protein level on POD 3, and heart rate on POD 3. In multivariate analysis, only the pancreas-to-muscle SIR on T1-w MRI (>1.37; odds ratio [OR] 23.25; 95% confidence interval [CI] 3.93-454.03; p < 0.01) and D-Amy level on POD 3 (>737 U/l; OR 3.91; 95% CI 1.02-16.36; p = 0.046) were identified as independent predictive factors.
CONCLUSIONS: The pancreas-to-muscle SIR on T1-w MRI and postoperative D-Amy levels were able to predict the development of POPF after DP. The pancreas-to-muscle SIR on T1-w MRI may be a potential objective biomarker reflecting pancreatic status.
© 2022. The Author(s).

Entities:  

Keywords:  Distal pancreatectomy; Postoperative pancreatic fistula; Signal intensity ratio on T1-weighted MRI

Mesh:

Substances:

Year:  2022        PMID: 35932021      PMCID: PMC9354425          DOI: 10.1186/s12957-022-02718-8

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   3.253


Background

Postoperative pancreatic fistula (POPF) is one of the most serious complications of pancreatic surgery for pancreatic disease. POPF causes secondary complications, such as abdominal abscess, delayed gastric emptying, and postoperative bleeding, and may lead to a prolonged hospital stay duration and surgery-related death [1-3]. Although surgical procedures have been standardized and surgical devices developed in pancreatic surgery, the incidence of POPF has been reported to still range from 3 to 50%, even at high-volume centers [4-7]. Furthermore, POPF still occurs at, as high as, 24 to 39% even after distal pancreatectomy (DP) without pancreaticoenteral anastomosis [8-13]. Therefore, POPF is considered to be caused by surgery-related factors and pancreas-related factors. Pancreatic parenchyma becomes hardened because of fibrosis, and the hardness of the pancreatic parenchyma is known to be associated with POPF [14, 15]. We previously reported a significant correlation between the pathological classification of the pancreatic fibrosis grade and the development of POPF [16, 17]. We also reported using the pancreas-to-muscle signal intensity ratio on T1-weighted MRI (SIR on T1-w MRI) to evaluate pancreatic fibrosis and predict POPF [16, 17]. This study aimed to assess the potential of the pancreas-to-muscle SIR on T1-w MRI as a predictive factor for POPF after DP.

Methods

Patients

In this single-center retrospective study, we included 134 consecutive patients who underwent DP for pancreatic disease at Gifu University Hospital between January 2010 and December 2021. All procedures were conducted by expert surgeons who had qualified through the board certification system of the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). We excluded 17 patients in total (simultaneous resection of other organs), so 117 patients were included in this study (Fig. 1). We conducted our study in accordance with the World Medical Association Declaration of Helsinki, and the Ethics Committee of Gifu University approved the study (approval number: 2021-026).
Fig. 1

Exclusion criteria

Exclusion criteria Patient characteristics were classified into three categories: pre-, intra-, and postoperative factors (Fig. 2). The six preoperative factors were age, sex, body mass index (BMI), pancreatic disease (pancreatic ductal adenocarcinoma (PDAC) or non-PDAC), tumor location, and the pancreas-to-muscle SIR on T1-w MRI. The six intraoperative factors included operative time, blood loss, surgical procedure ((i) open or laparoscopic surgery, (ii) spleen preserving or non-preserving), pancreatic resection procedure (hand-sewn or stapler), pancreas texture (soft or hard), and pancreas thickness measured intraoperatively on resection site. Finally, the five postoperative factors included the amylase concentration levels of drainage fluid (D-Amy), the white blood cell (WBC) count, C-reactive protein (CRP) level, body temperature, and heart rate on postoperative day (POD) 1 and 3. Body temperature was the maximum value and heart rate was the average value on the measurement day.
Fig. 2

Analysis flow chart for identifying predictive factors for postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP)

Analysis flow chart for identifying predictive factors for postoperative pancreatic fistula (POPF) after distal pancreatectomy (DP)

Perioperative management

In cases of DP for PDAC, regional lymph node dissection with splenectomy following the classification of pancreatic carcinoma of the Japan Pancreas Society [18] and pancreatic resection of the portal vein were performed. In the case of DP for non-PDAC, systematic lymph node dissection was omitted, and pancreatic resection was performed with sufficient margin from the tumor. Pancreatic resection was performed with a hand-sewn closure or using a linear stapler. In the hand-sewn closure group, the pancreas was resected after identifying the main pancreatic duct, and the main pancreatic duct was ligated with a 3-0 silk suture. The stump of the remnant pancreas was closed with a vertical mattress suture using 5-0 polypropylene. For the group that underwent pancreatic resection using a linear stapler, the pancreas was resected with a purple or black cartridge using Endo GIA™ Tri-Staple or Signia™ stapling system (Medtronic plc., Dublin, Ireland). The closed jaw was clamped carefully and slowly, taking 5 min, at a fixed speed. The firing was performed at 1 cm per minute by firmly fixing the stapler. After firing, the jaws of the stapler were held shut for 1 min. One 19Fr. Blake silicon drain (Johnson and Johnson Inc. New Brunswick, NJ, USA) was then placed near the stump of the remnant pancreas. The drain was removed on POD 4–5, when the drainage fluid was clear, the postoperative course was stable, and the patient was without abdominal pain, fever, or other symptoms. The D-Amy levels were measured on POD 1, 3, and 5. All patients received prophylactic antibiotics (cefmetazole) only intraoperatively or 2 days postoperatively.

The pancreas-to-muscle signal intensity ratio on T1-weighted MRI

Previously, we studied the potential value of preoperative MRI in evaluating pancreatic properties [16, 17] and reported that the pancreas-to-muscle SIR on T1-w MRI significantly correlated with pancreatic fibrosis and that it may be a potential biomarker for predicting POPF for pancreatic surgery. The pancreatic parenchyma’s signal intensity (SI) on the portal vein and the paraspinal muscle was measured using fat-suppressed axial T1-weighted imaging (Fig. 3). The pancreas-to-muscle SIR on T1-w MRI was calculated using the following equation: [SI of the pancreatic parenchyma]/[SI of the paraspinal muscle].
Fig. 3

The pancreas-to-muscle signal intensity ratio on fat-suppressed axial T1-weighted MRI was calculated by [signal intensity of the pancreatic parenchyma] (arrow)/[signal intensity of the paraspinal muscle] (arrowhead)

The pancreas-to-muscle signal intensity ratio on fat-suppressed axial T1-weighted MRI was calculated by [signal intensity of the pancreatic parenchyma] (arrow)/[signal intensity of the paraspinal muscle] (arrowhead)

Definition of POPF

In this study, we included only clinically symptomatic POPF. Therefore, only grades B and C pancreatic fistulas were defined as POPF (grade B, symptomatic fistula requiring therapeutic intervention such as antibiotics and percutaneous drainage; grade C, symptomatic fistula associated with a severe general condition of patients, sepsis, and multiorgan failure requiring aggressive treatment in the intensive care unit and surgical intervention), based on the International Study Group of Pancreatic Fistula (ISGPF) definitions [19]. Diagnosis day of POPF was defined as when intra-abdominal fluid collection with positive cultures was identified by ultrasonography (US) or computed tomography (CT).

Statistical analysis

Continuous variables were expressed as median (range) values, and categorical variables were expressed as frequencies (percentages). For comparisons of variables between the POPF and non-POPF groups, Fisher’s exact test was used for categorical variables. A Mann-Whitney U test was used for continuous variables. The predictive ability for POPF after DP was assessed by calculating the area under the receiver operating characteristic (ROC) curve. Youden’s index was used to determine the optimal cutoff value to calculate specificities and sensitivities in the ROC curve analysis. The variables identified as potentially significant by univariate analysis were selected for multivariate analysis with a logistic regression model to identify the independent predictors of POPF after DP. The limit of statistical significance for all analyses was defined as a 2-sided p-value of 0.05. All statistical analyses were performed using JMP software (SAS Institute Inc., Cary, NC, USA).

Results

Comparison of clinical outcomes between patients with and without POPF

In total, 117 patients underwent DP for pancreatic disease. Symptomatic POPF occurred in 29 (24.8 %) patients. Patients’ clinical outcomes after DP are summarized in Table 1. The median time at which POPF was confirmed was POD 7 (3–25 days). In the patients with POPF, the median time until hospital discharge was 35 days postoperatively (range, 12–121 days), and two patients had died within 30 postoperative days. A comparison between patients with and without POPF indicated significant differences in hospital stay duration (p < 0.01).
Table 1

Comparison of clinical outcomes between patients with and without POPF after distal pancreatectomy

Patients with POPF (n = 29)Patients without POPF (n = 88)p-value
Diagnosis days of POPF (day)7 (3–25)--
Grade of POPFa-
 Grade B27 (93.1)-
 Grade C2 (6.9)-
Treatment for POPF・Drain replacement and irrigation19 (65.5)--
・Endoscopic transgastric drainage7 (24.1)
・Antibiotics and octreotide3 (10.4)
Postoperative death within 30 days2 (6.9)0 (0.0)0.06
Hospital days (days)35 (12–121)13 (7–23)<0.01

Data are expressed as median (range) or number of patients (percentage)

POPF Postoperative pancreatic fistula

aInternational Study Group (ISGPS) definition and grading of POPF as follows: grade B, symptomatic fistula requiring therapeutic intervention such as antibiotics and percutaneous drainage; grade C, symptomatic fistula associated with a severe general condition of patients, sepsis, and multiorgan failure requiring aggressive treatment in the intensive care unit and surgical intervention

✝p < 0.05

Comparison of clinical outcomes between patients with and without POPF after distal pancreatectomy Data are expressed as median (range) or number of patients (percentage) POPF Postoperative pancreatic fistula aInternational Study Group (ISGPS) definition and grading of POPF as follows: grade B, symptomatic fistula requiring therapeutic intervention such as antibiotics and percutaneous drainage; grade C, symptomatic fistula associated with a severe general condition of patients, sepsis, and multiorgan failure requiring aggressive treatment in the intensive care unit and surgical intervention ✝p < 0.05

Comparison of pre-, intra-, and postoperative status between patients with and without POPF

Table 2 summarizes the 17 factors (classified into three categories) compared between patients with and without POPF.
Table 2

Comparison of pre-, intra-, and postoperative status between patients with and without POPF after distal pancreatectomy

Patients with POPF(n=29)Patients without POPF(n=88)p-value
PreoperativeAge (years)67 (40–82)67 (11–84)0.87
Sex
 Male18 (62.1)50 (56.8)0.67
 Female11 (37.9)38 (43.2)
BMI (kg/m2)23.6 (17.6–32.2)22.4 (16.2–32.2)0.37
Pancreatic ductal adenocarcinoma12 (41.4)43 (48.9)0.53
Location
 Body14 (48.3)54 (61.4)0.28
 Tail15 (51.7)34 (38.6)
Pancreas-to-muscle SIR on T1-w MRI1.64 (1.25–2.68)1.35 (0.74–2.16)<0.01
IntraoperativeOperative time (min)284 (174–537)264 (143–564)0.13
Blood loss (ml)190 (10–1910)260 (0–1840)0.84
Surgical procedure
 Open23 (79.3)60 (68.2)0.35
 Laparoscopic6 (20.7)28 (31.8)
 Spleen preserving3 (10.3)15 (17.1)0.56
 Non-spleen preserving26 (89.7)73 (82.9)
Resection procedure
 Hand-sewn11 (37.9)36 (40.9)0.83
 Stapler18 (62.1)52 (59.1)
Pancreas texture
 Soft21 (72.4)54 (61.4)0.37
 Hard8 (27.6)34 (38.6)
Pancreas thickness (mm)11 (8–17)12 (3–24)0.46
PostoperativeD-Amy levels (U/l)
 POD 17652 (108–34076)1899 (42–61075)0.02
 POD 31290 (42–16515)403 (35–43873)<0.01
WBC (×103/μl)
 POD 112.6 (7.5–26.5)11.1 (5.3–18.2)<0.01
 POD 313.3 (5.9–26.9)11.3 (3.9–23.9)0.048
CRP (mg/dl)
 POD 19.3 (1.8–15.4)8.3 (0.2–17.5)0.16
 POD 320.1 (8.0–33.5)14.5 (0.3–26.5)<0.01
Body temperature (°C)
 POD 138.0 (37.1–39.4)38.0 (36.9–39.3)0.55
 POD 337.4 (36.1–38.9)37.4 (36.2–39.4)0.30
Heart rate (bpm)
 POD 198 (81–142)92 (61–122)0.07
 POD 388 (72–111)82 (56–119)<0.01

Data are expressed as median (range) or number of patients

POPF Postoperative pancreatic fistula, BMI Body mass index, pancreas-to-muscle SIR on T-w MRI the pancreas-to-muscle signal intensity ratio on unenhanced T1-weigthed magnetic resonance imaging, D-Amy drainage fluid amylase concentration, POD Postoperative day, WBC White blood cell, CRP C-reactive protein

✝p< 0.05

Comparison of pre-, intra-, and postoperative status between patients with and without POPF after distal pancreatectomy Data are expressed as median (range) or number of patients POPF Postoperative pancreatic fistula, BMI Body mass index, pancreas-to-muscle SIR on T-w MRI the pancreas-to-muscle signal intensity ratio on unenhanced T1-weigthed magnetic resonance imaging, D-Amy drainage fluid amylase concentration, POD Postoperative day, WBC White blood cell, CRP C-reactive protein ✝p< 0.05 Among preoperative factors, the pancreas-to-muscle SIR on T1-w MRI was significantly higher in the POPF group than in the non-POPF group (p < 0.01). Among intraoperative factors, there was no significant difference between the two groups. Among postoperative factors, the D-Amy level on POD 1 and 3 (p = 0.02 and p < 0.01, respectively), WBC on POD 1 and 3 (p < 0.01 and p = 0.048, respectively), CRP level on POD 3 (p < 0.01), and heart rate on POD 3 (p < 0.01) were significantly higher in the POPF group than in the non-POPF group.

Cutoff values of the pancreas-to-muscle SIR on T1-w MRI and D-Amy levels for predicting POPF

The ROC curves for generating the cutoff values of the pancreas-to-muscle SIR on T1-w MRI and D-Amy level on POD 1 and 3 are shown in Fig. 4. The cutoff value of the pancreas-to-muscle SIR on T1-w MRI was +1.37, with an area under the curve (AUC) of 0.741, a sensitivity of 96.3%, and specificity of 52.0% (Fig. 4a). The cutoff value of the D-Amy level on POD 1 was 7238 U/l, with an AUC of 0.729, a sensitivity of 55.2%, and a specificity of 80.5% (Fig. 4b). The cutoff value of the D-Amy level on POD 3 was 737 U/l, with an AUC of 0.721, a sensitivity of 72.4%, and a specificity of 65.5% (Fig. 4c).
Fig. 4

Receiver operating characteristic (ROC) curve analysis of pancreas-to-muscle SIR on T1-weighted MRI and D-Amy level on POD 1 and 3 for discriminating to POPF

Receiver operating characteristic (ROC) curve analysis of pancreas-to-muscle SIR on T1-weighted MRI and D-Amy level on POD 1 and 3 for discriminating to POPF

Uni- and multivariate analysis of prediction for POPF after DP

In a univariate logistic regression analysis, POPF after DP was significantly associated with the pancreatic-to-muscle SIR on T1-w MRI (p < 0.01), D-Amy level on POD 1 and 3 (both p < 0.01), WBC on POD 1 and 3 (p < 0.01 and p = 0.04, respectively), CRP level on POD 3 (p < 0.01), and heart rate on POD 3 (p = 0.02). A multivariate logistic regression analysis revealed that the pancreas-to-muscle SIR on T1-w MRI (>1.37; odds ratio [OR] 23.25; 95% confidence interval [CI] 3.93–454.03; p < 0.01) and D-Amy level on POD 3 (>737 U/l; OR 3.91; 95% CI 1.02–16.36; p = 0.046), were independent predictive factors of POPF after DP (Table 3).
Table 3

Uni- and multivariate predictive factors of POPF after DP

nUnivariateMultivariate
OR95% CIp-valueOR95% CIp-value
PreoperativeAge (years)
 >70450.790.32–1.890.61
 <70721
Sex
 Male681.240.53–3.010.62
 Female491
BMI (kg/m2)
 >24392.070.85–5.000.10
 <24771
Pancreatic ductal adenocarcinoma
 Yes550.740.31–1.720.48
 No621
Location
 Body680.590.25–1.370.22
 Tail491
Pancreas-to-muscle SIR on T1-w MRI
 >1.376129.75.83–543.73<0.0123.253.93–454.03<0.01
 <1.374111
IntraoperativeOperative time (min)
 >300381.360.55–3.240.50
 <300781
Blood loss (ml)
 >400390.860.33–2.070.73
 <400771
Surgical procedure
 Open831.790.69–5.280.24
 Laparoscopic341
 Spleen preserving180.560.12–1.870.37
 Non-spleen preserving991
Resection procedure
 Hand-sewn470.880.36–2.070.78
 Stapler701
Pancreas texture
 Soft751.650.68–4.350.28
 Hard421
Pancreas thickness (mm)
 >12560.710.30–1.640.42
 <12611
PostoperativeD-Amy levels (U/l)—POD 1
 >7238335.072.07–12.78<0.011.210.31–4.750.78
 <72388311
D-Amy levels (U/l)—POD 3
 >737514.992.04–13.25<0.013.911.02–16.360.046
 <7376511
WBC (×103/μl)—POD 1
 >1.20483.161.34-7.75<0.012.440.69–9.120.17
 <1.206911
WBC (×103/μl)—POD 3
 >1.40342.591.07–6.290.041.030.27–3.730.96
 <1.408311
CRP (mg/dl)—POD 1
 >10401.510.63–3.580.35
 <10771
CRP (mg/dl)—POD 3
 >20343.891.61–9.60<0.012.750.75–10.700.13
 <208311
Body temperature (°C)—POD 1
 >38.0710.740.32–1.750.49
 <38.0461
Body temperature (°C)—POD 3
 >38.0140.470.07–1.870.31
 <38.01031
Heart rate (bpm)—POD 1
 >100382.050.85–4.880.11
 <100791
Heart rate (bpm)—POD 3
 >100134.351.32–14.810.023.840.77–21.400.10
 <10010411

POPF Postoperative pancreatic fistula, OR Odds ratio, 95% CI 95% Confidence interval, BMI Body mass index, pancreas-to-muscle SIR on T-w MRI the pancreas-to-muscle signal intensity ratio on unenhanced T1-weigthed magnetic resonance imaging, D-Amy drainage fluid amylase concentration, POD Postoperative day, WBC White blood cell, CRP C-reactive protein

✝p < 0.05

Uni- and multivariate predictive factors of POPF after DP POPF Postoperative pancreatic fistula, OR Odds ratio, 95% CI 95% Confidence interval, BMI Body mass index, pancreas-to-muscle SIR on T-w MRI the pancreas-to-muscle signal intensity ratio on unenhanced T1-weigthed magnetic resonance imaging, D-Amy drainage fluid amylase concentration, POD Postoperative day, WBC White blood cell, CRP C-reactive protein ✝p < 0.05

Discussion

A high incidence of POPF is still reported in pancreatic surgery despite ongoing attempts to reduce its frequency with the development of surgical techniques and devices [4-13]. The clinical nuisance of POPF is that delayed therapeutic intervention can lead to secondary complications [1-3]. This can lead to severe disease and prolonged treatment. In this study, patients with POPF showed an increase in hospital stay duration and mortality. Furthermore, we have previously studied that in PDAC cases, the onset of POPF leads to a delay in initiating postoperative adjuvant chemotherapy [20]. Thus, POPF may affect not only short-term, but also long-term prognosis. Therefore, early and accurate diagnosis of POPF and the promptest possible interventions possible are required. However, this study’s median time for POPF diagnosis was 7 days (range, 3–25), making early diagnosis difficult with only routine postoperative examination. We identified two predictive factors for POPF: (i) the pancreas-to-muscle SIR on T1-w MRI > 1.37 and (ii) the D-Amy level on POD 3 > 737 U/l. D-Amy levels are among the most established predictive factors for POPF. Therefore, the definition of POPF according to the ISGPF offers the definitive diagnosis according to the D-Amy level on POD 3. In this study, D-Amy levels were also significantly correlated with POPF. There is no doubt that amylase in the drainage fluid is useful in predicting POPF, as has been reported many times [21-42]. However, the following remain somewhat unclear: (1) the optimal timing of measurement, (2) the optimal cutoff value, (3) the optimal drain placement site, and (4) whether drainage fluid concentration or the total amount of amylase is more reliable. In addition, postoperative drain obstruction due to fibrin or clots, and drain misalignment often occurs, interfering with accurate D-Amy level measurements. The nature of the pancreas itself is thought to play a profound role in the development of POPF. In particular, the texture of pancreatic parenchyma (soft pancreas) has been an important risk factor for POPF. However, the problem is that the pancreatic texture is very subjective and cannot be quantified. To solve this problem, we previously investigated the correlation between preoperative pancreatic MRI features and the histopathological pancreatic fibrosis grade of surgical specimens (fibrosis was graded as follows: F0 = normal pancreatic parenchyma, no fibrotic changes; F1 = mild fibrosis with thickening of periductal fibrosis tissue; F2 = moderate fibrosis with marked sclerosis of interlobular septa and no evidence of architectural changes; and F3 = severe fibrosis with detection of architectural destruction) [16, 17]. We found that the pancreas-to-muscle SIR on T1-w MRI significantly correlated with the pancreatic fibrosis grade. This is because normal pancreatic parenchyma exhibits hyperintensity on T1-w MRI, as pancreatic juice is rich in glycoproteins, and the endoplasmic reticulum within the pancreatic cells contributes to the T1 shortening effect. However, the signal intensity gradually decreases with the progression of pancreatic atrophy, fibrosis, interstitial edema, or fat deposition [43, 44]. In our previous study, the mean pancreas-to-muscle SIR on T1-w MRI values for F0 and F1, which correspond to the soft pancreas, were 1.51 and 1.48, respectively. Furthermore, the pancreas-to-muscle SIR on T1-w MRI in patients with POPF was significantly higher than that in patients without POPF. Based on these findings, we hypothesized that the pancreas-to-muscle SIR on T1-w MRI might be a potential biomarker for predicting POPF and calculated the cutoff value of 1.41 [16]. Yoon et al. conducted a similar study and reported the mean pancreas-to-muscle SIR on T1-w MRI values for F0 and F1 and the cutoff value for predicting POPF was 1.51, 1.48, and 1.40, respectively [45]. Interestingly, the calculated cutoff value for predicting POPF (1.37) in this study is very close to previous studies. This study had some limitations. First, it was retrospective in design, was undertaken at a single institution, and involved a small number of study patients. The relatively small sample size may have caused a selection bias and multiplicity issues in statistical analysis. This limitation should be considered when evaluating our study results. A prospective, multi-centered study is needed involving a larger number of patients in the future. Second, there were the technical variations in the surgical procedure of DP, such as open or laparoscopic, spleen preserving or non-preserving, hand-sewn or stapler, and lymph node dissection or not. This study found no significant correlation between surgical-related factors and POPF. It is necessary to unify surgical techniques in order to calculate more appropriate cutoff values of the pancreas-to-muscle SIR on T1-weighted MRI and D-Amy levels.

Conclusions

We found that the pancreas-to-muscle SIR on T1-weighted MRI and D-Amy levels may have predictive value for POPF. The pancreas-to-muscle SIR is an objective and quantitative biomarker reflecting pancreatic characteristics. Postoperative management based on the pancreas-to-muscle SIR on T1-weighted MRI may contribute to a shortened hospital stay.
  44 in total

1.  Pancreatic fistula after distal pancreatectomy: predictive risk factors and value of conservative treatment.

Authors:  Virginie Pannegeon; Patrick Pessaux; Alain Sauvanet; Marie-Pierre Vullierme; Reza Kianmanesh; Jacques Belghiti
Journal:  Arch Surg       Date:  2006-11

Review 2.  Postoperative pancreatic fistula: an international study group (ISGPF) definition.

Authors:  Claudio Bassi; Christos Dervenis; Giovanni Butturini; Abe Fingerhut; Charles Yeo; Jakob Izbicki; John Neoptolemos; Michael Sarr; William Traverso; Marcus Buchler
Journal:  Surgery       Date:  2005-07       Impact factor: 3.982

3.  Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients.

Authors:  Manabu Kawai; Masaji Tani; Hiroshi Terasawa; Shinomi Ina; Seiko Hirono; Ryohei Nishioka; Motoki Miyazawa; Kazuhisa Uchiyama; Hiroki Yamaue
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  Transection using bipolar scissors reduces pancreatic fistula after distal pancreatectomy.

Authors:  Manabu Kawai; Masaji Tani; Hiroki Yamaue
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-08-01

5.  Novel diagnostics for aggravating pancreatic fistulas at the acute phase after pancreatectomy.

Authors:  Mitsuro Kanda; Tsutomu Fujii; Hideki Takami; Masaya Suenaga; Yoshikuni Inokawa; Suguru Yamada; Daisuke Kobayashi; Chie Tanaka; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

6.  Risk factor analysis and prevention of postoperative pancreatic fistula after distal pancreatectomy with stapler use.

Authors:  Motokazu Sugimoto; Naoto Gotohda; Yuichiro Kato; Shinichiro Takahashi; Takahiro Kinoshita; Hidehito Shibasaki; Shogo Nomura; Masaru Konishi; Hironori Kaneko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-06       Impact factor: 7.027

7.  A thick pancreas is a risk factor for pancreatic fistula after a distal pancreatectomy: selection of the closure technique according to the thickness.

Authors:  Hidetoshi Eguchi; Hiroaki Nagano; Masahiro Tanemura; Yutaka Takeda; Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Koji Umeshita; Masaki Mori; Yuichiro Doki
Journal:  Dig Surg       Date:  2011-02-04       Impact factor: 2.588

8.  The influence of transection site on the development of pancreatic fistula in patients undergoing distal pancreatectomy: A review of 294 consecutive cases.

Authors:  Naomi M Sell; Michael J Pucci; Salil Gabale; Benjamin E Leiby; Ernest L Rosato; Jordan M Winter; Charles J Yeo; Harish Lavu
Journal:  Surgery       Date:  2015-03-16       Impact factor: 3.982

9.  Predictive factors associated with postoperative pancreatic fistula after laparoscopic distal pancreatectomy: a 10-year single-institution experience.

Authors:  Arturo S Mendoza; Ho-Seong Han; Soyeon Ahn; Yoo-Seok Yoon; Jai Young Cho; YoungRok Choi
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

10.  Distal pancreatectomy utilizing a flexible stapler closure eliminates the risk of pancreas-related factors for postoperative pancreatic fistula.

Authors:  Y Kawabata; T Nishi; T Tanaka; S Yano; Y Tajima
Journal:  Eur Surg Res       Date:  2013-04-23       Impact factor: 1.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.